Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Consistency of the Immunogenicity of a GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults Aged Between 18 and 60 Years

NCT00449670 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00449670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00449670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Consistency of the Immunogenicity of a GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults Aged Between 18 and 60 Years
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
March 24, 2007
Completion date
June 10, 2008
Enrollment
1,206 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, influenza vaccines